These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11649187)

  • 1. How an investigator and an IRB cooperated in research design.
    Benotti JR; Shannon TA
    IRB; 1982; 4(6):6-7. PubMed ID: 11649187
    [No Abstract]   [Full Text] [Related]  

  • 2. Approving high risk, rejecting low risk: the case of two cases.
    Shannon TA; Ockene IS; Levine RJ
    IRB; 1985; 7(1):6-8. PubMed ID: 11649618
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethics of drug experimentation.
    Sgreccia E
    Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol review within the context of a research program.
    Miller FG; Rosenstein DL
    IRB; 1998; 20(4):7-10. PubMed ID: 11657088
    [No Abstract]   [Full Text] [Related]  

  • 6. The ethics of phase I pediatric oncology trials.
    Ackerman TF
    IRB; 1995; 17(1):1-5. PubMed ID: 11653060
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimating risks and benefits in AIDS vaccine and drug trials.
    Kessel E
    AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
    [No Abstract]   [Full Text] [Related]  

  • 8. The moral imperatives of medical research in human subjects.
    Lieberman JA; Sloan J
    J Calif Alliance Ment Ill; 1994; 5(1):40-2. PubMed ID: 11653319
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 10. The paradoxical case of payment as benefit to research subjects.
    Macklin R
    IRB; 1989; 11(6):1-3. PubMed ID: 11650284
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical considerations in human experimentation.
    Bernstein JE
    J Clin Pharmacol New Drugs; 1975; 15(8-9):579-90. PubMed ID: 11661224
    [No Abstract]   [Full Text] [Related]  

  • 12. Policies and quality assurance in the pharmaceutical industry.
    Shamoo AE
    Account Res; 1991; 1(4):273-84. PubMed ID: 11651459
    [No Abstract]   [Full Text] [Related]  

  • 13. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 14. Constraints on experimentation: protecting children to death.
    Holder AR
    Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241
    [No Abstract]   [Full Text] [Related]  

  • 15. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-2-3):99-103. PubMed ID: 11650154
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of placebos in randomized clinical trials.
    Levine RJ; Schafer A
    IRB; 1985; 7(2):1-6. PubMed ID: 11649622
    [No Abstract]   [Full Text] [Related]  

  • 18. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
    Siris ES; Burrell CD
    IRB; 1983; 5(6):1-5. PubMed ID: 11649526
    [No Abstract]   [Full Text] [Related]  

  • 19. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD
    IRB; 1993; 15(5):1-7. PubMed ID: 11659703
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical-trials bottleneck.
    Russo F
    Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.